Executive Summary
22 contract option exercises totaling $3.38B obligations signal robust federal demand for IT services, construction, biotech R&D, and space/defense, with 86% bullish ratings providing multi-year revenue visibility to 2049 for firms like Booz Allen (2 awards, $818M), Lockheed Martin (2, $79M), and SAIC ($59M). Concentrations in GSA (6 awards) and HHS/BARDA biotech highlight steady IT/infra spend amid disaster recovery and biothreat priorities. Unexercised options exceed $2B across portfolio, offering high-upside triggers, though firm-fixed-price structures and low outlays (avg ~30% disbursed) flag execution risks.
Tracking the trend? Catch up on the prior Contract Option Exercises digest from February 19, 2026.
Investment Signals(4)
- GSA IT/Engineering Boom(HIGH)▲
6 GSA awards totaling $581M obligations (e.g., Booz Allen $746M, SAIC $59M, Manta $73M) in NAICS 541512/541330 underscore multi-year IT and engineering demand through 2027+.
- Biothreat Biotech Commitments(HIGH)▲
HHS/BARDA awards to Paratek ($265M to 2029) and Luminary Labs ($100M to 2028) signal sustained R&D funding in NAICS 541714 amid biothreat priorities.
- Space/Defense Longevity(MEDIUM)▲
NASA awards to Lockheed Martin total $79M with potential to $372M through 2049, plus Textron Aviation $134M FAA aircraft to 2031, affirm decade+ revenue in aerospace.
- Disaster Recovery Infra Surge(HIGH)▲
DoD ($616M hospital) and USDA ($242M Helene bridges/roads) construction awards provide $859M firm commitments through 2028.
Risk Flags(3)
- Execution[HIGH RISK]▼
Firm-fixed-price on 11 contracts ($2.1B total) exposes to cost overruns/inflation, esp. long-duration (e.g., Textron to 2031, Kiewit disaster recovery).
- Execution[MEDIUM RISK]▼
Low aggregate outlays (~30% of obligations, 10 contracts at $0) signal delayed revenue realization across IT/construction.
- Market[MEDIUM RISK]▼
Heavy subawards (e.g., Peraton $258M/53 subs, Amentum $16M/70) >20% of value on multiple awards risk margin erosion.
Opportunities(3)
- ◆
$2B+ unexercised options (e.g., Peraton $142M, SAIC $268M, Lockheed $297M) across 16 contracts offer 2x+ upside on exercise.
- ◆
Long-tail contracts to 2049 (Lockheed NASA) and 2039 (Saab FAA) position for follow-ons in space/IT radar.
- ◆
Small biz set-asides (5 awards, $345M) in GSA/engineering/biotech enable repeat wins for qualifiers.
Sector Themes(3)
- ◆
12 awards ($1.6B, 48% total) in NAICS 541512/541611 via GSA/DHS/VA signal entrenched demand for systems design/management.
- ◆
HHS/BARDA biotech contracts ($365M to 2029) amid biothreat focus, with full obligations/low outlays.
- ◆
$1.1B in construction (DoD/USDA) for hospitals/bridges post-Helene, firm-fixed to 2028.
Watch List(4)
- 👁
{"entity"=>"Booz Allen Hamilton (BAH)", "reason"=>"Largest recipient (2 awards, $818M GSA/VA IT), 19% of total value with $431M options.", "trigger"=>"Q1 FY27 earnings for obligation conversion"}
- 👁
{"entity"=>"Lockheed Martin (LMT)", "reason"=>"NASA space awards ($79M, $372M potl to 2049) extend core backlog.", "trigger"=>"GEOXXO milestone payments"}
- 👁
{"entity"=>"SAIC", "reason"=>"$59M GSA IT ($327M potl to 2033), no outlays yet but massive option upside.", "trigger"=>"initial outlays >$10M"}
- 👁
{"entity"=>"Peraton Enterprise Solutions", "reason"=>"$211M DHS TSA IT with stop-work flags and $142M options to 2028.", "trigger"=>"stop-work resolution"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 22 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC